We are live on ! Find out more
BNTX icon

BioNTech

282 hedge funds and large institutions have $4.34B invested in BioNTech in 2023 Q4 according to their latest regulatory filings, with 70 funds opening new positions, 91 increasing their positions, 70 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

84% more first-time investments, than exits

New positions opened: 70 | Existing positions closed: 38

30% more repeat investments, than reductions

Existing positions increased: 91 | Existing positions reduced: 70

12% more funds holding

Funds holding: 252282 (+30)

8% more capital invested

Capital invested by funds: $4.01B → $4.34B (+$330M)

1.92% more ownership

Funds ownership: 15.42%17.33% (+1.9%)

5% more call options, than puts

Call options by funds: $234M | Put options by funds: $224M

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

Holders
282
Holders Change
+30
Holders Change %
+11.9%
% of All Funds
4.11%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
70
Increased
91
Reduced
70
Closed
38
Calls
$234M
Puts
$224M
Net Calls
+$10.8M
Net Calls Change
+$12.2M
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of New York Mellon
151
Bank of New York Mellon
New York
$402K +$384K +3,811 New
SAM
152
Sectoral Asset Management
Quebec, Canada
$393K +$28.2K +280 +8%
Cambridge Investment Research Advisors
153
Cambridge Investment Research Advisors
Iowa
$391K -$27.3K -271 -7%
OC
154
Oppenheimer & Co
New York
$388K -$310K -3,078 -46%
HF
155
HRT Financial
New York
$375K +$358K +3,556 New
VEA
156
Virtus ETF Advisers
New York
$331K +$40.1K +398 +15%
CIAS
157
Capital Investment Advisory Services
North Carolina
$326K
WC
158
Waterloo Capital
Texas
$326K +$311K +3,085 New
BCI
159
Brinker Capital Investments
Pennsylvania
$324K +$292K +2,898 New
OPS
160
Orion Portfolio Solutions
Nebraska
$324K +$292K +2,898 New
Prudential Financial
161
Prudential Financial
New Jersey
$321K +$307K +3,042 New
CCM
162
CAAS Capital Management
New York
$317K +$302K +3,000 New
TRCT
163
Tower Research Capital (TRC)
New York
$315K +$52.7K +523 +21%
MPPLM
164
Midwest Professional Planners Ltd (MPPL)
Wisconsin
$313K +$14.4K +143 +5%
MML Investors Services
165
MML Investors Services
Massachusetts
$311K +$297K +2,945 New
TSS
166
Two Sigma Securities
New York
$295K +$83.3K +827 +42%
Pathstone Holdings
167
Pathstone Holdings
New Jersey
$287K +$274K +2,721 New
RJA
168
Raymond James & Associates
Florida
$284K -$291K -2,889 -52%
CSS
169
Cubist Systematic Strategies
Connecticut
$277K +$265K +2,626 New
GCM
170
Gallacher Capital Management
Colorado
$277K +$63.5K +630 +32%
VF
171
Virtu Financial
New York
$274K +$262K +2,600 New
Mitsubishi UFJ Asset Management
172
Mitsubishi UFJ Asset Management
Japan
$274K -$24K -238 -9%
PNC Financial Services Group
173
PNC Financial Services Group
Pennsylvania
$273K +$176K +1,743 +208%
New York State Common Retirement Fund
174
New York State Common Retirement Fund
New York
$270K
JF
175
Jump Financial
Illinois
$268K +$256K +2,540 New

BNTX Hedge Fund Activity: Q4 2023 in Review

282 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q4 2023, worth a combined $4.34B — up 8.2% from $4.01B a quarter earlier.

Buyers outnumbered sellers: 70 funds opened new BNTX positions and 38 closed out — a net gain of 32 holders — while 91 added to existing stakes and 70 trimmed.

The largest buyer was Harding Loevner, opening a new position worth an estimated $397M. The largest seller was Artisan Partners, cutting an estimated $67.6M.

  • 282 institutional investors held BioNTech (BNTX) as of Q4 2023, up from 252 in Q3 2023.
  • Funds reported $4.34B of BioNTech stock for Q4 2023, up 8.2% quarter-over-quarter.
  • 70 funds opened new BioNTech positions in Q4 2023 and 38 closed out, a net change of +32 holders.
  • The largest BioNTech buyer in Q4 2023 was Harding Loevner, an estimated $397M added.
  • The largest BioNTech seller in Q4 2023 was Artisan Partners, an estimated $67.6M sold.

Based on aggregated 13F filings for Q4 2023.